This site is intended for healthcare professionals only.

This site is intended for healthcare professionals only.

Case navigator:
Managing brain metastases in HER2-positive NSCLC

With Enriqueta Felip

This video-based case study will cover the prevalence, clinical impact, and management of brain metastases in HER2-positive NSCLC, including the limitations of traditional therapy and the safety and efficacy of HER2-targeted therapies in patients with brain metastases.
Photo of Enriqueta Felip

Log in to access

General information

Title: Managing brain metastases in HER2-positive NSCLC

Release date: July XX, 2026

Expiration date: July  XX, 2026

Estimated time to complete activity: 15 minutes

Target audience

This program is intended for oncologists, pathologists, pulmonologists and oncology nurses, physician assistants, and those in the multidisciplinary teams worldwide who provide front-line care for patients with NSCLC.

Learning objectives

Following completion of this independent educational program, you will be able to:

Accreditation

Credits available

Completing one Case Navigator activity will earn you 0.25 AMA PRA Category 1 Credit(s)™. You can earn a total of 0.5 credits for both activities.

In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Springer Healthcare IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

As part of the planning committee Katie Long and Jules Morgan have no interests to disclose. The PIM staff has no financial relationships to disclose. All relevant financial relationships have been mitigated.